High AR S96 phosphorylation is associated with poor overall survival and disease-free survival in HCC patients, highlighting the cooperative role of AR and mTORC1 in driving liver tumor progression and providing a potential target for HCC treatment (58) (Figure 2D). The gene discussed is AR; the disease is hepatocellular carcinoma.